AAAAAA
Results: 1-25/32
Authors:
Vacha, P
Buttner, H
Bohle, A
Feyerabend, T
Citation: P. Vacha et al., Radiotherapy of bladder cancer, UROLOGE A, 40(5), 2001, pp. 376
Authors:
Buttner, H
Feyerabend, T
Bohle, A
Citation: H. Buttner et al., Radiation therapy for transitional cell carcinoma of the bladder - concomitant radio-chemotherapy, UROLOGE A, 40(5), 2001, pp. 380
Authors:
Bohle, A
Durek, C
Citation: A. Bohle et C. Durek, The use of BCG in superficial carcinoma of the urinary bladder, UROLOGE A, 40(5), 2001, pp. 403-409
Authors:
Brandau, S
Bohle, A
Citation: S. Brandau et A. Bohle, Bladder cancer I. Molecular and genetic basis of carcinogenesis, EUR UROL, 39(5), 2001, pp. 491-497
Authors:
Kausch, I
Bohle, A
Citation: I. Kausch et A. Bohle, Bladder cancer II. Molecular aspects and diagnosis, EUR UROL, 39(5), 2001, pp. 498-506
Authors:
Brandau, S
Bohle, A
Citation: S. Brandau et A. Bohle, Activation of natural killer cells by bacillus Calmette-Guerin, EUR UROL, 39(5), 2001, pp. 518-524
Authors:
Durek, C
Richter, E
Basteck, A
Rusch-Gerdes, S
Gerdes, J
Jocham, D
Bohle, A
Citation: C. Durek et al., The fate of bacillus Calmette-Guerin after intravesical instillation, J UROL, 165(5), 2001, pp. 1765-1768
Authors:
Bohle, A
Baumgartel, M
Gotz, ML
Muller, EH
Jocham, D
Citation: A. Bohle et al., Burn-out of urologists in the county of Schleswig-Holstein, Germany: A comparison of hospital and private practice urologists, J UROL, 165(4), 2001, pp. 1158-1161
Authors:
Bohle, A
Buttner, H
Jocham, D
Citation: A. Bohle et al., Primary treatment of condylomata acuminata with viable bacillus Calmette-Guerin, J UROL, 165(3), 2001, pp. 834-836
Authors:
Brandau, S
Riemensberger, J
Jacobsen, M
Kemp, D
Zhao, WC
Zhao, XQ
Jocham, D
Ratliff, TL
Bohle, A
Citation: S. Brandau et al., NK cells are essential for effective BCG immunotherapy, INT J CANC, 92(5), 2001, pp. 697-702
Authors:
Frohn, C
Doehn, C
Durek, C
Bohle, A
Schlenke, P
Jocham, D
Kirchner, H
Citation: C. Frohn et al., Feasibility of the adoptive transfusion of allogenic human leukocyte antigen-matched natural killer cells in patients with renal cell carcinoma, J IMMUNOTH, 23(4), 2000, pp. 499-504
Authors:
Brandau, S
Suttmann, H
Riemensberger, J
Seitzer, U
Arnold, J
Durek, C
Jocham, D
Flad, HD
Bohle, A
Citation: S. Brandau et al., Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guerin-activated killer cells, CLIN CANC R, 6(9), 2000, pp. 3729-3738
Authors:
Brandau, S
Bohle, A
Thanhauser, A
Ernst, M
Mattern, T
Ulmer, AJ
Flad, HD
Citation: S. Brandau et al., In vitro generation of bacillus Calmette-Guerin-activated killer cells, CLIN INF D, 31, 2000, pp. S94-S100
Authors:
Bohle, A
Thanhauser, A
Ernst, M
Flad, HD
Rusch-Gerdes, S
Jocham, D
Ulmer, AJ
Citation: A. Bohle et al., Reduction of side effects of intravesical therapy with bacille Calmette-Guerin by pentoxifylline? An in vitro approach, CLIN INF D, 31, 2000, pp. S101-S105
Authors:
Wittes, RC
Bohle, A
Bakshi, S
Bretscher, P
Brewer, T
Clements, D
Fanning, A
Flad, H
Garcia, LF
Gheorghiu, M
Hershfield, E
Hoft, D
Jewett, M
Kunimoto, D
Lamm, D
Marks, D
Menzies, R
Mosmann, T
Plotkin, S
Prescott, S
Ratliff, T
Schamhart, D
Smith, D
Tilley, P
Ward, B
Citation: Rc. Wittes et al., Bacille Calmette-Guerin vaccine - Discussion, CLIN INF D, 31, 2000, pp. S115-S121
Authors:
Brandau, S
Suttmann, H
Flad, HD
Jocham, D
Bohle, A
Citation: S. Brandau et al., Killing of Fas ligand-resistant renal carcinoma cells by interleukin-2-andBCG-activated effector cells, CANCER IMMU, 49(7), 2000, pp. 369-376
Authors:
Bohle, A
Citation: A. Bohle, Bacillus Calmette-Guerin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract - Editorial comment, EUR UROL, 38(6), 2000, pp. 705-705
Authors:
Bohle, A
Citation: A. Bohle, BCG's mechanism of action - Increasing our understanding, EUR UROL, 37, 2000, pp. 1-8
Authors:
Durek, C
Rusch-Gerdes, S
Jocham, D
Bohle, A
Citation: C. Durek et al., Sensitivity of BCG to modern antibiotics, EUR UROL, 37, 2000, pp. 21-25
Authors:
Bohle, A
Citation: A. Bohle, BCG: The optimal approach in superficial bladder cancer, EUR UROL, 37, 2000, pp. 37-39
Authors:
Ardelt, P
Bohle, A
Citation: P. Ardelt et A. Bohle, Gene therapy of bladder cancer, AKT UROL, 31(7), 2000, pp. 403-412
Authors:
Jurczok, A
Gunther, J
Durek, C
Wulf, T
Brandau, S
Jocham, D
Bohle, A
Citation: A. Jurczok et al., Optimizing of the orthotopic murine bladder cancer model and its use in the evaluation for intravesical bacillus Calmette-Guerin immunotherapy, AKT UROL, 31(7), 2000, pp. 424-430
Authors:
Kausch, I
Bohle, A
Citation: I. Kausch et A. Bohle, Molecular aspects of bladder carcinoma part II. Molecular diagnostics, AKT UROL, 31(4), 2000, pp. 212-228
Authors:
Brandau, S
Bohle, A
Citation: S. Brandau et A. Bohle, The molecular and genetic basis of bladder cancer carcinogenesis, AKT UROL, 31(3), 2000, pp. 149-156
Authors:
Doehn, C
Bohle, A
Jocham, D
Citation: C. Doehn et al., Intra-abdominal abscess due to patient non-compliance after construction of an ileal neobladder: Case report and review of the literature, INT J UROL, 6(5), 1999, pp. 264-267